Monirah M Almurdhi1, Neil D Reeves2, Frank L Bowling1, Andrew J M Boulton1, Maria Jeziorska1, Rayaz A Malik3. 1. Centre for Endocrinology and Diabetes, Institute of Human Development, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, U.K. 2. School of Healthcare Science, Faculty of Science and Engineering, Manchester Metropolitan University, Manchester, U.K. 3. Centre for Endocrinology and Diabetes, Institute of Human Development, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, U.K. Weill Cornell Medical College, Doha, Qatar ram2045@qatar-med.cornell.edu.
Abstract
OBJECTIVE: Muscle weakness and atrophy of the lower limbs may develop in patients with diabetes, increasing their risk of falls. The underlying basis of these abnormalities has not been fully explained. The aim of this study was to objectively quantify muscle strength and size in patients with type 2 diabetes mellitus (T2DM) in relation to the severity of neuropathy, intramuscular noncontractile tissue (IMNCT), and vitamin D deficiency. RESEARCH DESIGN AND METHODS: Twenty patients with T2DM and 20 healthy control subjects were matched by age, sex, and BMI. Strength and size of knee extensor, flexor, and ankle plantar and dorsiflexor muscles were assessed in relation to the severity of diabetic sensorimotor polyneuropathy (DSPN), amount of IMNCT, and serum 25-hydroxyvitamin D (25OHD) levels. RESULTS: Compared with control subjects, patients with T2DM had significantly reduced knee extensor strength (P = 0.003) and reduced muscle volume of both knee extensors (P = 0.045) and flexors (P = 0.019). Ankle plantar flexor strength was also significantly reduced (P = 0.001) but without a reduction in ankle plantar flexor (P = 0.23) and dorsiflexor (P = 0.45) muscle volumes. IMNCT was significantly increased in the ankle plantar (P = 0.006) and dorsiflexors (P = 0.005). Patients with DSPN had significantly less knee extensor strength than those without (P = 0.02) but showed no difference in knee extensor volume (P = 0.38) and ankle plantar flexor strength (P = 0.21) or volume (P = 0.96). In patients with <25 nmol/L versus >25 nmol/L 25OHD, no significant differences were found for knee extensor strength and volume (P = 0.32 vs. 0.18) and ankle plantar flexors (P = 0.58 vs. 0.12). CONCLUSIONS: Patients with T2DM have a significant reduction in proximal and distal leg muscle strength and a proximal but not distal reduction in muscle volume possibly due to greater intramuscular fat accumulation in distal muscles. Proximal but not distal muscle strength is related to the severity of peripheral neuropathy but not IMNCT or 25OHD level.
OBJECTIVE:Muscle weakness and atrophy of the lower limbs may develop in patients with diabetes, increasing their risk of falls. The underlying basis of these abnormalities has not been fully explained. The aim of this study was to objectively quantify muscle strength and size in patients with type 2 diabetes mellitus (T2DM) in relation to the severity of neuropathy, intramuscular noncontractile tissue (IMNCT), and vitamin D deficiency. RESEARCH DESIGN AND METHODS: Twenty patients with T2DM and 20 healthy control subjects were matched by age, sex, and BMI. Strength and size of knee extensor, flexor, and ankle plantar and dorsiflexor muscles were assessed in relation to the severity of diabetic sensorimotor polyneuropathy (DSPN), amount of IMNCT, and serum 25-hydroxyvitamin D (25OHD) levels. RESULTS: Compared with control subjects, patients with T2DM had significantly reduced knee extensor strength (P = 0.003) and reduced muscle volume of both knee extensors (P = 0.045) and flexors (P = 0.019). Ankle plantar flexor strength was also significantly reduced (P = 0.001) but without a reduction in ankle plantar flexor (P = 0.23) and dorsiflexor (P = 0.45) muscle volumes. IMNCT was significantly increased in the ankle plantar (P = 0.006) and dorsiflexors (P = 0.005). Patients with DSPN had significantly less knee extensor strength than those without (P = 0.02) but showed no difference in knee extensor volume (P = 0.38) and ankle plantar flexor strength (P = 0.21) or volume (P = 0.96). In patients with <25 nmol/L versus >25 nmol/L 25OHD, no significant differences were found for knee extensor strength and volume (P = 0.32 vs. 0.18) and ankle plantar flexors (P = 0.58 vs. 0.12). CONCLUSIONS:Patients with T2DM have a significant reduction in proximal and distal leg muscle strength and a proximal but not distal reduction in muscle volume possibly due to greater intramuscular fat accumulation in distal muscles. Proximal but not distal muscle strength is related to the severity of peripheral neuropathy but not IMNCT or 25OHD level.
Authors: Steven J Brown; Joseph C Handsaker; Frank L Bowling; Andrew J M Boulton; Neil D Reeves Journal: Diabetes Care Date: 2015-03-12 Impact factor: 19.112
Authors: Lisa Ceglia; Sathit Niramitmahapanya; Mauricio da Silva Morais; Donato A Rivas; Susan S Harris; Heike Bischoff-Ferrari; Roger A Fielding; Bess Dawson-Hughes Journal: J Clin Endocrinol Metab Date: 2013-10-09 Impact factor: 5.958
Authors: Kendra A Young; Janet K Snell-Bergeon; Ramachandra G Naik; John E Hokanson; David Tarullo; Peter A Gottlieb; Satish K Garg; Marian Rewers Journal: Diabetes Care Date: 2010-10-26 Impact factor: 19.112
Authors: M R Lopes; Paula A B Ribeiro; Priscila Ledur; Gabriela C Souza; Nadine Clausell; Beatriz D Schaan Journal: J Diabetes Res Date: 2014-08-25 Impact factor: 4.011
Authors: Helen Sheahan; Kimberley Canning; Nishka Refausse; Ewan M Kinnear; Greg Jorgensen; James R Walsh; Peter A Lazzarini Journal: Int Wound J Date: 2017-07-13 Impact factor: 3.315
Authors: Patrick J Ferrara; Anthony R P Verkerke; J Alan Maschek; Justin L Shahtout; Piyarat Siripoksup; Hiroaki Eshima; Jordan M Johnson; Jonathan J Petrocelli; Ziad S Mahmassani; Thomas D Green; Joseph M McClung; James E Cox; Micah J Drummond; Katsuhiko Funai Journal: FASEB J Date: 2021-10 Impact factor: 5.834
Authors: Eric D Buras; Kimber Converso-Baran; Carol S Davis; Takeshi Akama; Fumihito Hikage; Daniel E Michele; Susan V Brooks; Tae-Hwa Chun Journal: Diabetes Date: 2018-10-25 Impact factor: 9.461
Authors: Ryan P McGrath; Brenda M Vincent; Soham Al Snih; Kyriakos S Markides; Brad P Dieter; Ryan R Bailey; Mark D Peterson Journal: J Aging Health Date: 2017-06-19
Authors: Monirah M Almurdhi; Neil D Reeves; Frank L Bowling; Andrew J M Boulton; Maria Jeziorska; Rayaz A Malik Journal: Diabetes Care Date: 2016-10 Impact factor: 19.112